CareRx Corporation

TSX:CRRX.TO

Medical - Care Facilities

Healthcare
$3.21 +0.63%

+$0.02 today

Market cap
$203.06M
Beta
0.62
P/E (TTM)
7.4
EPS (TTM)
$0.43
Dividend yield
1.88%
52W Low $2.70High $4.00

Volume 0.01M

Average 0.04M

CRRX.TO Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

CareRx CorporationTSX: CRRX.TO

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables grows, but more slowly than its trailing trend

Q1 FY2026 accounts receivables of CA$558K rose 61.7% year over year, behind the +237.7% change in trailing-twelve-month accounts receivables. Sequentially, it rose 2690.0% from the prior quarter. Over 3 fiscal years it compounded at -45.3% a year.

Context

  • Accounts receivables amounted to 0.1% of revenue in FY2025, down 1.0 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +61.7% toward the trailing-twelve-month pace of +237.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$558K+2690.0% QoQ
Last fiscal yearDec 2025
CA$247K-93.5% YoY
LTMMar 2026
CA$460K+237.7% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+61.7%——
1 year-93.5%——
3-year CAGR-45.3%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

CAD · from the cash flow

Latest · FY2025
247K CAD
Year-over-year change
-93.5%

Accounts Receivables vs competitors

How CRRX.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +237.7% is the highest of 6, against a peer median of -119.6%.
  • Accounts receivables amounts to 0.1% of revenue for CRRX.TO, versus a peer median of 1.7%.
CRRX.TO Competitors
Accounts Receivables for CRRX.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DR.TOMedical Facilities CorporationLTM Mar 2026$6.55M USD-297.0%+15.7%2.1%
PRN.TOProfound Medical Corp.LTM Mar 2026$3.48M USD-925.6%-55.1%18.6%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$1.92M CAD+165.8%-76.6%1.2%
CRRX.TOCareRx CorporationLTM Mar 2026CA$460K CAD+237.7%-45.3%0.1%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$114.76K USD-108.9%—0.2%
HBP.TOHelix BioPharma Corp.LTM Apr 2026CA$11K CAD-119.6%——
Peer median (excluding CRRX.TO) —-119.6%-55.1%1.7%

Competitors are the stored peer set for CRRX.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(22.73M)(34.35M)(5.41M)(4.5M)26.13M
Depreciation & Amortization15.39M20.07M19.98M19.19M18.33M
Deferred Income Tax(1.01M)(1.54M)(4.19M)32K(22.77M)
Stock-Based Compensation2.67M4.57M1.47M3.65M2.72M
Change in Working Capital(3.73M)638K2.12M8.98M(988K)
Accounts Receivables(11.72M)1.51M1.47M3.82M247K
Inventory(2.83M)(2M)648K1.55M(126K)
Accounts Payables15M816K(181K)3.46M(891K)
Other Working Capital(4.17M)307K186K145K(218K)
Other Non-Cash Items16.67M32.96M13.4M10.64M4.12M
Operating Cash Flow7.27M22.33M27.38M37.99M27.54M
Capital Expenditures(7.12M)(13.61M)(8.7M)(8.11M)(5.59M)
Acquisitions (Net)(86.13M)(2.99M)(3.66M)196K39K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities67K(3.57M)(3.93M)(2.53M)0
Investing Cash Flow(93.18M)(16.6M)(12.31M)(7.92M)(8.26M)
Debt Repayment30.35M(5.29M)(39.82M)(21.58M)(4.32M)
Common Stock Issued80.86M1.01M14.68M014K
Common Stock Repurchased00(56K)(801K)(2.24M)
Dividends Paid0000(1.26M)
Other Financing Activities(9.3M)(8.71M)(11.2M)(5.64M)(6.64M)
Financing Cash Flow101.91M(12.99M)(36.4M)(28.02M)(14.44M)
Effect of Forex Changes00000
Net Change in Cash16M(7.25M)(21.34M)2.06M4.84M
Free Cash Flow153K8.72M18.68M29.88M21.95M

CareRx Corporation

TSX:CRRX.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.